New allergy pill shows promise in ragweed season trial
NCT ID NCT06922448
First seen Jan 11, 2026 · Last updated May 21, 2026 · Updated 19 times
Summary
This study tested a new drug called BLU-808 in 21 adults with ragweed allergies. Participants were exposed to ragweed pollen in a special chamber to see if the drug safely reduces allergy symptoms like sneezing and itchy eyes. The goal was to check safety and how well the drug works for short-term symptom relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINOCONJUNCTIVITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Red Maple Trials
Ottawa, ON K1H E4, Canada
Conditions
Explore the condition pages connected to this study.